Kawaljeet K Bhatia, MD
Adolescent Medicine · Gilroy
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhatia’s office at (408) 848-5522 to ask if they take your plan before you enroll.
California Medical Board record
Licence A42050 · Current
Licensed to practise in California · since 1985 · expires 2027-05-31 · L.N. Mithila University, Darbhanga Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$36,718 in 2024
Medicaid paid $36,718 for 1,601 billed services this clinician did in 2024, up to 53 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 386 | $17,277 |
| Short return visit (20+ min) | 566 | $7,904 |
| Extended color vision examination | 181 | $3,001 |
| Screening test, pure tone, air only | 202 | $2,096 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 73 | $1,843 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 30 | $1,469 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 27 | $1,390 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 28 | $951 |
| Application of topical fluoride | 13 | $197 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 27 | $165 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 27 | $163 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 28 | $133 |
| 2024 | 1,601 | 13 | 53 | $36,718 |
| 2023 | 2,241 | 14 | 67 | $43,539 |
| 2022 | 1,890 | 14 | 75 | $28,146 |
| 2021 | 1,934 | 18 | 67 | $32,347 |
| 2020 | 1,300 | 12 | 73 | $20,154 |
| 2019 | 1,715 | 14 | 85 | $22,819 |
| 2018 | 1,442 | 13 | 89 | $10,018 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 509 | $19,375 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 141 | $4,641 |
| Extended color vision examination | 228 | $3,739 |
| Short return visit (20+ min) | 726 | $3,706 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 79 | $3,173 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 48 | $2,791 |
| Screening test, pure tone, air only | 238 | $2,578 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $1,517 |
| Service | 12 | $516 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 53 | $456 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 58 | $368 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 45 | $277 |
2022
| Developmental screening | 256 | $5,957 |
| Short return visit (20+ min) | 735 | $3,569 |
| Extended color vision examination | 199 | $3,424 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 89 | $3,087 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 94 | $2,973 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 53 | $2,715 |
| Screening test, pure tone, air only | 207 | $2,348 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $1,753 |
| Service | 14 | $602 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 71 | $532 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 27 | $453 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 71 | $435 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 156 | $6,652 |
| Short return visit (20+ min) | 642 | $5,873 |
| Extended color vision examination | 212 | $3,758 |
| Developmental screening | 200 | $2,815 |
| Screening test, pure tone, air only | 217 | $2,548 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 34 | $2,187 |
| Service | 49 | $2,108 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 57 | $1,956 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 30 | $835 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 16 | $773 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 31 | $706 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 82 | $652 |
2020
| Short return visit (20+ min) | 676 | $4,265 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 69 | $4,176 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 64 | $2,739 |
| Service | 48 | $2,065 |
| Extended color vision examination | 86 | $1,573 |
| Screening test, pure tone, air only | 122 | $1,451 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 24 | $1,227 |
| Developmental screening | 72 | $729 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 12 | $725 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 53 | $526 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 37 | $338 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 37 | $338 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 100 | $7,166 |
| Short return visit (20+ min) | 965 | $4,195 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 71 | $3,001 |
| Extended color vision examination | 124 | $2,295 |
| Screening test, pure tone, air only | 177 | $2,140 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 82 | $859 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 16 | $773 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 66 | $642 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 54 | $618 |
| Service | 12 | $516 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $247 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 12 | $129 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 39 | $1,572 |
| Extended color vision examination | 83 | $1,536 |
| Short return visit (20+ min) | 973 | $1,161 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 24 | $1,160 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 14 | $962 |
| Pure tone audiometry (threshold); air only | 48 | $705 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 71 | $704 |
| Screening test, pure tone, air only | 57 | $699 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 41 | $439 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 13 | $408 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $325 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 25 | $244 |
Money from drug and device companies
$177 in 2025
| 2025 | 4 | 7 | None | $177 |
| 2024 | 4 | 4 | None | $88 |
| 2023 | 4 | 6 | None | $94 |
| 2022 | 4 | 5 | None | $84 |
| 2021 | 3 | 3 | None | $56 |
| 2019 | 2 | 2 | None | $43 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Seqirus USA | Flucelvax | $66 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $54 | 2 payments
|
| GlaxoSmithKline | Bexsero | $42 | 2 payments
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
See all 7 published payments
| Seqirus USA | Meals · 2025-11-21 | Flucelvax | $35 |
| Merck Sharp & Dohme | Meals · 2025-10-27 | Gardasil 9 | $29 |
| Merck Sharp & Dohme | Meals · 2025-09-17 | Vaxneuvance | $25 |
| GlaxoSmithKline | Meals · 2025-05-21 | Bexsero | $18 |
| GlaxoSmithKline | Meals · 2025-02-12 | Bexsero | $24 |
| Cranial Technologies | Meals · 2025-01-30 | Doc Band | $15 |
| Seqirus USA | Meals · 2025-01-29 | Flucelvax | $31 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $88
| Seqirus USA | Flucelvax | $26 | 1 payment
|
| Pfizer | Comirnaty | $23 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $20 | 1 payment
|
| GlaxoSmithKline | Bexsero | $19 | 1 payment
|
2023: $94
| Cranial Technologies | Doc Band | $39 | 3 payments
|
| Pfizer | Prevnar 20 | $20 | 1 payment
|
| Merck Sharp & Dohme | Vaxelis | $18 | 1 payment
|
| Sanofi Pasteur | Vaxelis | $17 | 1 payment
|
2022: $84
| Cranial Technologies | Doc Band | $36 | 2 payments
|
| GlaxoSmithKline | Bexsero | $21 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $16 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent | $12 | 1 payment
|
2021: $56
| Merck Sharp & Dohme | Gardasil 9 | $23 | 1 payment
|
| GlaxoSmithKline | Bexsero | $20 | 1 payment
|
| Cranial Technologies | Doc Band | $13 | 1 payment
|
2019: $43
| Sobi | Synagis | $26 | 1 payment
|
| Sanofi Pasteur | Pentacel | $17 | 1 payment
|
Professional record
- NPI
- 1598834517
- Licence
- CA A42050California A42050: Current · expires 2027-05-31
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A420500
- Taxonomy
- Federal specialty code 2080A0000X (2080A0000X)
- Mailing address
- 7888 Wren Ave Ste C137, Gilroy, CA, 95020
- NPI first listed
- 2006-11-06
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.